TABLE 12, [EuroQol-5 Dimensions, five-level version utility scores and QALYs]. - Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis

	Obs	Mean	SD	Minimum	Maximum
*EQ-5D-5L utility scores at 28 days*
Overall	1061	0.294	0.339	−0.285	1.000
Intervention arm	516	0.293	0.337	−0.285	1.000
Standard care arm	545	0.294	0.341	−0.285	1.000
*QALYs*
QALYs (no imputation)
Overall	1061	0.011	0.013	−0.010	0.038
Intervention arm	516	0.011	0.012	−0.010	0.038
Standard care arm	545	0.011	0.013	−0.010	0.038
QALYs (with imputation)
Overall	1581	0.012	0.013	−0.011	0.038
Intervention arm	785	0.012	0.013	−0.011	0.038
Standard care arm	796	0.013	0.013	−0.010	0.038

Cover of Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis

Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.

Health Technology Assessment, No. 28.76.

Curry N, Davenport R, Thomas H, et al.

Southampton (UK): National Institute for Health and Care Research; 2024 Nov.

This work was produced by Curry et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.